BIOHOPE WILL EXPLAIN THE PROMISING DATA FROM PILOT STUDY TO THEIR SCIENTIFIC ADVISORY BOARD
BIOHOPE will hold an investigator meeting with their Scientific Advisory Board on the 23rd of September (4:00 p.m.) at the NH Hotel Hesperia de Barcelona, under the framework of the European Society of Organ Transplantation (ESOT) congress, to be held in Barcelona this year.
The main objective of this meeting is to show and discuss the preliminary results of the use of IMMUNOBIOGRAM® in kidney transplanted patients from the BH-Pilot study, which is being carried out in the Hospitals Puerta de Hierro and La Paz, in Madrid. The final results are expected for 1Q2018.
These results are highly promising and indicate, if confirmed in the final analysis, a positive clinical concept test.
To date, the Kidney Transplant teams of several European top-level centers in the field of kidney transplantation have confirmed their participation: H. Universitario “del Mar” (Barcelona), H. University “Puerta de Hierro” (Madrid), H. University “La Paz” (Madrid), Rigshospitalet (Copenhagen), H. University “Vall d’Hebron” (Barcelona), Antwerp University Hospital – UZA (Belgium), Essen University Hospital (Germany), Wroclaw Medical University (Poland), Institute of Clinical and Experimental Medicine – IKEM (Prague, Czech Republic)
The preliminary results will be informed in more detail after the event.
